Author: Lynne Taylor

Big pharma was largely absent from merger and acquisition activity in 2013 but returned to vigorous deal-making last year with spending of nearly $90 billion; however, this group was outspent by specialty pharma, which deployed more than $130 billion in M&A transactions in 2014, says new research.

NHS England has launched a new programme to test innovative ways of diagnosing cancer more quickly at over 60 sites across the country.

A committee of MPs says it has found “huge” variations in funding for clinical commissioning groups (CCGs), ranging from £137 per person below their fair share of available funding in Corby to £361 per person above their fair share in West London.

The UK currently has three vaccines against the Ebola virus in the first phase of clinical trials, Health Secretary Jeremy Hunt has told MPs.

Health Secretary Jeremy Hunt has announced new measures to tackle sepsis which each year claims around 31,000 lives and costs the NHS in England about £2 billion.